In summary, the expression of PLOD1 in mesenchymal GBM was significantly higher than other subtypes, and the higher expression of PLOD1 predicted a significantly poorer prognosis in patients with GBM, suggesting that PLOD1 may play an important role in mesenchymal GBM or even in all GBM. This evidence concerns the gene PLOD1 and glioblastoma.